Company Filing History:
Years Active: 1984-1985
Title: **Innovative Contributions of Cheryl D Blume in Pharmaceutical Research**
Introduction
Cheryl D Blume is an accomplished inventor based in Morgantown, WV, known for her significant contributions to the field of pharmaceutical sciences. With a total of three patents to her name, Blume has made noteworthy advancements in combination pharmaceutical formulations, particularly aimed at improving patient outcomes.
Latest Patents
Among her latest inventions is a novel pharmaceutical combination composition and the associated method of creating it. This innovative formulation involves separately milling the active pharmaceutical ingredients and subsequently forming them into separate granules before blending them together. Notably, her work describes a combination of triamterene and hydrochlorothiazide, exhibiting improved bioavailability and effectiveness in preventing or eliminating hypokalemic side effects. This innovative approach highlights her commitment to enhancing the safety and efficacy of therapeutic treatments.
Career Highlights
Cheryl D Blume has been associated with Mylan Pharmaceuticals Inc., a leading global generic and specialty pharmaceuticals company. Her work at Mylan emphasizes her dedication to advancing pharmaceutical sciences through innovative research and development.
Collaborations
Collaboration plays a crucial role in scientific advancements, and Blume's partnerships include working closely with Paul H Bonner, a fellow research scientist. Together, they have contributed to the development of groundbreaking pharmaceutical compositions, showcasing their combined expertise and commitment to improving healthcare solutions.
Conclusion
Cheryl D Blume's inventive spirit and dedication to pharmaceutical innovation are reflected in her patented contributions to the field. Her work not only demonstrates her technical abilities but also highlights the importance of collaboration in advancing science. With continued efforts, she remains a significant figure in improving therapeutic options for patients worldwide.